M.D. Sass Investors Services, Inc. Pfizer Inc Transaction History

M.D. Sass Investors Services, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $713,592 - $1.02 Million	-26,400 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $144,848 - $164,384	-4,400 Reduced 14.29%	26,400 $1.03 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $240,426 - $311,762	-7,400 Reduced 19.37%	30,800 $1.11 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $183,750 - $201,880	-4,900 Reduced 11.37%	38,200 $1.62 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $689,400 - $836,200	-20,000 Reduced 31.7%	43,100 $1.9 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $310,011 - $330,503	-9,400 Reduced 12.97%	63,100 $2.29 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $360,583 - $418,326	11,300 Added 18.46%	72,500 $2.57 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $1.25 Million - $1.33 Million	-37,600 Reduced 38.06%	61,200 $2.22 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $3.06 Million - $3.37 Million	98,800	98,800 $3.53 Million

3,222

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of M.D. Sass Investors Services, Inc., based on Form 13F filings with the SEC.

Stay updated on M.D. Sass Investors Services, Inc. with notifications on news.